​

Aethlon Medical Stock (NASDAQ:AEMD)

RevenueOwnershipFinancialsChartTranscripts
Aethlon Medical by TradingView

Previous Close

$3.40

52W Range

$3.21 - $84.80

50D Avg

$5.07

200D Avg

$17.24

Market Cap

$2.57M

Avg Vol (3M)

$119.23K

Beta

1.64

Div Yield

-

AEMD Company Profile

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

14

IPO Date

Mar 04, 1999

Website

AEMD Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceMar 22Mar 21Mar 20
Govt Contract And Grant Revenue$294.17K$659.10K-
Government Contract Revenue--$650.19K

Fiscal year ends in Mar 25 | Currency in USD

AEMD Financial Summary

Mar 25Mar 24Mar 23
Revenue--$574.25K
Operating Income-$-12.64M$-11.90M
Net Income$-13.39B$-12.21M$-12.03M
EBITDA-$-11.85M$-11.66M
Basic EPS$-8.58$-4.86$-5.86
Diluted EPS$-8.58$-4.86$-5.90

Fiscal year ends in Mar 25 | Currency in USD

Latest Earnings Call Transcripts

Q2 26Nov 12, 25 | 4:30 PM
Q1 26Aug 13, 25 | 4:30 PM
Q4 25Jun 26, 25 | 4:30 PM

Peer Comparison

TickerCompany
LNAILunai Bioworks Inc.
ERNAErnexa Therapeutics Inc.
ADAPAdaptimmune Therapeutics plc
ALURAllurion Technologies Inc.
CODXCo-Diagnostics, Inc.
TNONTenon Medical, Inc.
VVOSVivos Therapeutics, Inc.
NVNOenVVeno Medical Corporation
XAIRBeyond Air, Inc.
IINNInspira Technologies Oxy B.H.N. Ltd.